KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Procter & Gamble (PG) EBITDA (2016 - 2025)

Procter & Gamble (PG) has disclosed EBITDA for 17 consecutive years, with $5.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA fell 6.53% to $5.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $20.1 billion, a 1.27% increase, with the full-year FY2025 number at $20.5 billion, up 10.28% from a year prior.
  • EBITDA was $5.4 billion for Q4 2025 at Procter & Gamble, down from $5.9 billion in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $5.9 billion in Q3 2025 to a low of $3.5 billion in Q2 2021.
  • A 5-year average of $4.7 billion and a median of $4.5 billion in 2024 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: dropped 7.41% in 2022, then grew 29.51% in 2024.
  • Procter & Gamble's EBITDA stood at $5.2 billion in 2021, then decreased by 7.41% to $4.8 billion in 2022, then dropped by 7.36% to $4.4 billion in 2023, then rose by 29.51% to $5.7 billion in 2024, then dropped by 6.53% to $5.4 billion in 2025.
  • Per Business Quant, the three most recent readings for PG's EBITDA are $5.4 billion (Q4 2025), $5.9 billion (Q3 2025), and $4.4 billion (Q2 2025).